Impact of a Biophoton Therapy on Patients With Brain Disorders

Description

Previous clinical studies revealed that the newly developed biophoton therapy has been safe and effective in treating patients with Alzheimer's disease, dementia, stroke, traumatic brain injury, or Parkinson's disease. The current study is to confirm the previous clinical observation by conducting as a randomized, triple-blinded, placebo-controlled prospective intervention clinical research. About 80 patients with brain disorder (Alzheimer's disease, dementia, stroke, traumatic brain injury, Parkinson's disease) will participate in the intervention clinical study at the Tesla MedBed Center located in Butler, PA.

Conditions

Brain Disorders - Alzheimer's Disease, Dementia, Parkinson's Disease, Traumatic Brain Injury

Talk to us

Study Overview

On this page

Study Details

Study overview

Previous clinical studies revealed that the newly developed biophoton therapy has been safe and effective in treating patients with Alzheimer's disease, dementia, stroke, traumatic brain injury, or Parkinson's disease. The current study is to confirm the previous clinical observation by conducting as a randomized, triple-blinded, placebo-controlled prospective intervention clinical research. About 80 patients with brain disorder (Alzheimer's disease, dementia, stroke, traumatic brain injury, Parkinson's disease) will participate in the intervention clinical study at the Tesla MedBed Center located in Butler, PA.

Impact of a Biophoton Therapy on Patients With Brain Disorders

Impact of a Biophoton Therapy on Patients With Brain Disorders

Condition
Brain Disorders - Alzheimer's Disease, Dementia, Parkinson's Disease, Traumatic Brain Injury
Intervention / Treatment

-

Contacts and Locations

Butler

Tesla MedBed Center, 139 Pittsburgh Road, Butler, PA 16001, Butler, Pennsylvania, United States, 16001

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Must meet conditions for approval.
  • * Must be 18-years or older and stay in a hotel.
  • * Must have a caregiver willing to support the participant's full involvement in the study. • The caregiver can assist in completing all study surveys.
  • * Can provide informed consent or can be assisted by caregiver.
  • * Can provide a clinical diagnosis of a brain disorder.
  • * Can complete all study procedures during the study.
  • * Must be fluent in English (or the Caregiver can fully translate).
  • * Women of childbearing age must provide results of a pregnancy test in order to participate.
  • * Any untreated mental illnesses, that would affect study participation. This will be judged by the caregiver, or by the clinical study medical expert.
  • * Someone that relies on a ventilator.
  • * Someone who has a deep brain stimulator, pacemaker, or any implanted electronic devices.
  • * Co-morbid conditions that would interfere with study activities or response to treatment, which may include severe chronic pulmonary disease, history of uncontrolled seizures, acute or chronic infectious illness, severe diabetes, kidney failure, or any end-of-life prognosis.
  • * Is participating in another investigational drug or device trial.
  • * Has an active infectious disease, such as COVID-19.
  • * Pregnant women.

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

First Institute of All Medicines,

Study Record Dates

2024-11-22